Epstein Project

EFTA00029238.pdf

Type
pdf
Source set
data-set-8

Original source

Extracted text

From: 
To: 
Cc: 
Subject: RE: 040721 -- SDNY — US v Maxwell -- Maxwell letter -- request from Reuters 
Date: Thu, 08 Apr 2021 14:32:50 +0000 
Thanks. 
From 
Sent: Thursday, April 8, 20219:21 AM 
To: 
Cc 
Subject: Fwd: 040721 SONY — US v Maxwell — Maxwell letter — request from Reuters 
Just FYA — we'll probably get similar inquiries today on the HIPAA issue. 
We declined to comment. 
Sent from my iPhone 
Begin forwarded message: 
From: "Stempel, Jonathan E. (Reuters) 
Date: April 8, 2021 at 9:14:16 AM EDT 
To: 
Subject: 040721 -- SDNY -- US v Maxwell -- Maxwell letter -- request from Reuters 
Hi from New York. Ghislaine Maxwell's lawyers have now responded in considerable color to the 
government's letter regarding the conditions at MDC. As you probably know, the DOJ's discussion about 
conditions in Maxwell's cell attracted much press attention. 
Leaving aside the question of whose assessment is more accurate, the defense is raising the question of whether 
the DOJ should be disclosing such information because of the potential it might contribute to poisoning the jury 
pool. (This could be a ground for appeal if Maxwell were convicted.) 
We would like the government's response to this letter, including its mindfulness about how its disclosures 
might affect Maxwell's right to a fair trial, and whether it would consent to future redactions of the type 
described in the final paragraph. 
Thanks in advance. 
--Jon 
Jonathan Stempel 
Correspondent, Reuters America LLC 
Thomson Reuters 
EFTA00029238


This e-mail is for the sole use of the intended recipient and contains information that may be privileged and/or 
confidential. If you are not an intended recipient, please notify the sender by return e-mail and delete this e-mail and 
any attachments. Certain required legal entity disclosures can be accessed on our website: 
https://www.thomsonreuters.com/en/resources/disclosures.html 
<040721 -- SDNY -- US v Maxwell -- Maxwell letter.pdf> 
EFTA00029239

Open in the interactive archive →